Trials24 is now part of SubjectWell
The integration of Trials24 into SubjectWell’s operations brings together two industry leaders who share a deep commitment to improving global healthcare.
Is your clinical trial’s patient recruitment challenging or delayed?
When your clinical trial sites are struggling to recruit patients as predicted, find more patients OutSite™ with Trials24. Speed up your enrollment now.
Why OutSite™ is the solution you are looking for
Clinical trials are suffering from ancient approaches to patient recruitment. Sites often can’t provide enough patients to complete your clinical trial and struggle to find new ones due to outdated recruitment strategies (e.g., print and out of home media, etc.). Our industry needs a smarter approach to patient recruitment.
When you are directly interacting with patients, patient organizations, and healthcare professionals (HCPs), our transparent OutSite approach changes everything to your advantage.
How OutSite™ can help you reach more patients and speed up enrollment
Our established processes and proven scientific methods enable us to deliver state of the art service while remaining completely transparent throughout the entire patient recruitment journey. Our structured methodology makes OutSite™ universally applicable in any clinical trial phase, indication, or situation.
OutSite™ gives you insights and analytics for better predictability
OutSite™ Feasibility answers the question, “Do we have enough patients to conduct this study?”. Before launching your clinical trial, we are giving you patient recruitment certainty.
After providing you with enrollment prediction models on your specific patient population, OutSite™ Patient Recruitment helps to ensure your clinical trial’s last patient out (LPO) date.
What Our Sponsors, CROs, and Sites Say About Us
Sara Cazzaniga
Clinical R&D Manager Italfarmaco S.p.A., LinkedIn
"We have found that the team at Trials24 has a solid understanding of the recruitment issues relating to clinical trials in rare disease and are enjoyable and professional to work with. They efficiently set up the complete process of patient community involvement including the clinical trial website, and everything was specific and tailored to our needs. We were very impressed with the number of interested and eligible patients going up exponentially within short time...”
Dr. med. Peter Uebel
Specialist in Internal Medicine, Haus der Gesundheit Ludwigshafen, LinkedIn
“In a recent study, Trials 24 greatly supported recruiting potential study participants. Thanks to good pre-selection, we recruited some patients for the study. We were very grateful for this support. We have been established as a study center in internal and gastroenterological studies for more than 20 years. During this time, we have often used supporting campaigns in patient acquisition. Often with little success or a lack of pre-selection, which previously represented an ineffective additional burden.“
Dr. med. René Goedkoop
Acting Chief Medical Officer, Medigene AG, LinkedIn
"We embraced Admedicum’s services, in collaboration with Trials24, only by the time that we became aware that the inclusion of patients with certain hematologic malignancies in an ongoing phase I study of a PRAME-specific TCR-T was not as expected due to the very restrictive nature of the eligibility criteria. The team’s experience and creativity towards a fruitful approach to our reality of clinical study conduct within Germany..."
"We have found that the team at Trials24 has a solid understanding of the recruitment issues relating to clinical trials in rare disease and are enjoyable and professional to work with. They efficiently set up the complete process of patient community involvement including the clinical trial website, and everything was specific and tailored to our needs. We were very impressed with the number of interested and eligible patients going up exponentially within short time..."
Sara Cazzaniga
Clinical R&D Manager Italfarmaco S.p.A., LinkedIn
"In a recent study, Trials 24 greatly supported recruiting potential study participants. Thanks to good pre-selection, we recruited some patients for the study. We were very grateful for this support. We have been established as a study center in internal and gastroenterological studies for more than 20 years. During this time, we have often used supporting campaigns in patient acquisition. Often with little success or a lack of pre-selections, which previously represented an ineffective additional burden."
Dr. med. Peter Uebel
Specialist in Internal Medicine, Haus der Gesundheit Ludwigshafen, LinkedIn
"We embraced Admedicum’s services, in collaboration with Trials24, only by the time that we became aware that the inclusion of patients with certain hematologic malignancies in an ongoing phase I study of a PRAME-specific TCR-T was not as expected due to the very restrictive nature of the eligibility criteria. The team’s experience and creativity towards a fruitful approach to our reality of clinical study conduct within Germany..."
Dr. med. René Goedkoop
Acting Chief Medical Officer, Medigene AG, LinkedIn
About Us
Trials24 accelerates patient recruitment to support biopharmaceutical companies and CROs complete their clinical trials on time, bringing innovative drugs to patients faster.
We are here to support you
Do you want to learn more about how you can use the OutSite solutions in your clinical trial? Contact us now.
